Firmicutes is a broad bacterial phylum that includes many intestinal organisms. Bacillota is a newer name you may encounter. A high Firmicutes result should not be translated into “too many bad bacteria”: members of this group have different functions and clinical significance.
On this page
One category contains many different organisms
Roseburia, Lactobacillus and other familiar groups have been classified within Firmicutes. Some members are studied for useful metabolic activities; others can cause disease in particular circumstances. A phylum total cannot distinguish these roles or identify a harmful strain. [1]
How the GI-MAP value is used
The report includes a Firmicutes measurement and a Firmicutes:Bacteroidetes ratio. They describe different calculations. A high Firmicutes quantity does not automatically mean the ratio is high, because the Bacteroidetes value also affects the result. [2]
What a high result cannot explain
It cannot establish why someone has gained weight, diagnose metabolic disease or specify a weight-loss diet. Studies using the ratio as an obesity marker have produced inconsistent results. Applying a population association to one stool sample gives more certainty than the evidence supports. [3]
Likewise, a low value is not a direct measure of butyrate production. The abundance of a large bacterial group and the metabolites it produces are different measurements.
Useful context for interpretation
Compare the report’s units and assay with prior results before interpreting a trend. Bring symptom changes, recent antibiotics and dietary changes to the appointment. The goal is to answer a clinical question, not to reduce an entire phylum simply because it is flagged.
Common questions
Is all Firmicutes harmful?
No. The category is too broad for a good-versus-bad label. Species, strain, location and clinical context matter.
Does a normal Firmicutes level mean my gut is healthy?
No single broad count can establish overall gut health or rule out disease.
Sources and review
Sources checked October 7, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.
- Sheridan et al.: Carbohydrate utilization by Roseburia and related bacteria, 2016
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
- The Firmicutes/Bacteroidetes ratio: a review of the evidence, 2020
Medical review of this article is pending. For a correction or source question, contact GI MAP Test.